설명

Diabetes is one of the top 10 causes of death globally. It causes distress, disability, and premature death. A diabetic person experiences high glucose level in their blood, either because the beta cells do not produce insulin (유형 1 diabetes) that is required for the breakdown of glucose, or because the insulin produced is not utilized properly (유형 2 diabetes). The global continuous glucose monitoring market is set to grow by US$ 3 10억 동안 2021-2027, 연평균 성장률로 성장 (CAGR) ~의 14.6% 예측 기간 동안, 데이터 및 분석 회사 StrategyHelix에 따르면. Rise in incidence of diabetes cases, government support initiatives to constrict the spread of diabetes and increasing obesity population are expected to boost the market growth in the coming years.

이 보고서는 기간 동안 최신 시장 규모 데이터를 제공합니다. 2017-2020 그리고 예측 2027 covering key market aspects like sales value for continuous glucose monitoring. The global continuous glucose monitoring market is segmented on the basis of component, demographics, 최종 사용자, 및 지역. By component, it is categorized into sensors, and durables (receivers and transmitter). The sensors segment held the largest market share in 2020. By demographics, the continuous glucose monitoring market is divided into child population (≤14 years), and adult population (>14 years). The adult population (>14 years) segment accounted for the largest market share in 2020. 최종 사용자 기준, the continuous glucose monitoring market is divided into diagnostics/clinics, ICU, and home healthcare.

The report has profiled some of the key players of the market such as A. Menarini Diagnostics S.r.l., Abbott Laboratories, Dexcom Inc., Echo Therapeutics Inc., GlySens Incorporated, Insulet Corporation, LifeScan Inc., Medtronic MiniMed Inc, Roche Diabetes Care GmbH, Senseonics Holdings Inc..

이 보고서는 이 업계에서 활동하는 회사 및 조직에 매우 귀중한 리소스입니다.. It provides a cohesive picture of the continuous glucose monitoring market to help drive informed decision making for industry executives, 정책 입안자, 학생, 및 분석가.

보고 범위

요소: 센서, and durables (receivers and transmitter)
Demographics: child population (≤14 years), and adult population (>14 years)
최종 사용자: diagnostics/clinics, ICU, and home healthcare
지역: 북아메리카, 아시아 태평양, 유럽, 및 기타 국가 (열)
고려한 연도: 이 보고서는 기간을 다룹니다 2017 에게 2027

이해관계자를 위한 주요 이점

Get a comprehensive picture of the global continuous glucose monitoring market
현지 데이터 및 분석을 기반으로 지역 전략 및 전략적 우선순위 파악
성장 분야 및 투자 동향 파악
Understand what the future of the global continuous glucose monitoring market looks like
경쟁 구도 및 기회의 창 식별

목차

1. 시장 정의
2. 연구 방법론
3. 시장 데이터 & 시야
3.1 시장 가치
3.2 시장 가치 예측
4. Continuous Glucose Monitoring Market by Component
4.1 Sensors
4.2 Durables (Receivers And Transmitter)
5. Continuous Glucose Monitoring Market by Demographics
5.1 Child Population (≤14 Years)
5.2 Adult Population (>14 Years)
6. Continuous Glucose Monitoring Market by End User
6.1 Diagnostics/Clinics
6.2 Icus
6.3 Home Healthcare
7. Continuous Glucose Monitoring Market by Region
7.1 북아메리카
7.2 아시아 태평양
7.3 유럽
7.4 나머지 세계 (열)
8. 회사 프로필
8.1 ㅏ. Menarini Diagnostics S.r.l.
8.2 Abbott Laboratories
8.3 Dexcom Inc.
8.4 Echo Therapeutics, 주식회사.
8.5 GlySens Incorporated
8.6 Insulet Corporation
8.7 LifeScan, 주식회사.
8.8 Medtronic MiniMed Inc
8.9 Roche Diabetes Care GmbH
8.10 센세오닉스 홀딩스, 주식회사.
9. 부록
9.1 스트래티지헬릭스 소개
9.2 부인 성명